Mylan in patent settlement with Shionogi, CIMA for Prednisolone ODT Pharmaceutical Business Review Mylan has signed a settlement and license agreements with Shionogi and CIMA Labs regarding Prednisolone sodium phosphate orally disintegrating tablets (ODT), known generically as Orapred ODT. Mylan said that following the settlement agreement, it is ... |
